GMI Research estimated Left Ventricular Assist Device segment to capture the largest revenue share in 2018 and the forecast period, growing at a CAGR of 9.7% during 2018-2025

The Egypt Ventricular Assist Device market exhibited a value of USD XX million in 2018, and is expected to reach USD XX million by 2025, growing at a CAGR of 9.0% during 2018-2025.

The market driver of the ventricular assist device market are:

• Rising cases of heart failures in the region.
• Rise in transition to minimally invasive surgical procedure to adoption from conventional surgeries
• Government initiatives and public-private collaboration in healthcare
• Introduction of novel technological advanced products such as Duraheart etc.

Ventricular Assist Device market in Egypt is expanding owing to increased healthcare expenditure in the region and the direct presence of major players in the region. In addition, advancement in the product technology and shortage of heart donors have contributed to the market growth.

Transcutaneous design type is estimated to have the highest growth rate in the forecast period owing to its advanced specifications. Implantable design type segment held the maximum revenue share in 2018 and is expected to dominate during the forecast period due to its low cost.

Left Ventricular Assist Device segment held the maximum revenue share in the device segment in 2017 and is expected to hold its dominance in the Egypt region in the forecast period as well owing to product advancement and mainly damaging of left ventricle in the heart failure.

Bridge-to-transplant Application segment captured the maximum revenue in 2018 because of increasing rate of heart failures in the region. However, the Bride-to-recovery segment is expected to flourish in the forecast period due to increase in number of heart donors.

The major players are focusing on product launches, spreading awareness regarding the cardiac diseases and their treatment through campaigns and investing in research and development to keep leadership in the competitive Egypt Ventricular Assist Device–GMI Research

Key takeaways/key essentials:

• Transcutaneous design type is expected to grow at the fastest rate in the forecast period.
• Left ventricular assist device is more popular in the region as the heart failure is mainly caused by the left ventricular malfunctioning.

Various notable players operating in Egypt Ventricular Assist Device Market are Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed among others.

The Egypt Ventricular Assist Device market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices

The research report “Egypt Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in Middle East and Africa, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, Please Visit: https://www.gmiresearch.com/report/egypt-ventricular-assist-device-vad-market/

Early buyers will get customization upto 25% on report

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com